Skip to main content
Glama

Compare Entities

compare_entities
Read-onlyIdempotent

"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valuesYesFor company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]).

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. First observed

TDQS

A4.7/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Despite annotations already declaring readOnly, idempotent, and non-destructive, the description adds substantial behavioral context: parallel execution, SEC EDGAR/XBRL data sourcing, off-calendar fiscal year handling, sorting by primary metric, and citation URI returns. No contradiction with annotations.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

Description is dense but well-structured: trigger phrases lead, followed by usage rule, type-specific data details, and return info. Minor redundancy in repeating the benefit over sequential lookups, but every sentence earns its place.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness4/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Covers both entity types, sorting behavior, return format (paired data + citation URIs), and performance benefit. Without an output schema, it could be more explicit about exact return fields for each type, but it is complete enough for a complex tool with two modes.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters4/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100% with clear descriptions for type and values. The description enriches semantics by specifying what type='company' pulls (revenue, net income, cash, long-term debt) and type='drug' pulls (FAERS, FDA approvals, trials), adding value beyond the schema.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

Description explicitly states side-by-side comparison of 2–5 companies or drugs in ONE parallel call, with trigger phrases like 'X vs Y' and 'rank these companies.' It clearly distinguishes itself from sequential lookups and sibling tools by emphasizing entity comparison versus single-entity lookups.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines5/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

Provides explicit when-to-use rule: 'ALWAYS PREFER over sequential single-pack lookups when comparing entities.' Also lists natural-language triggers and differentiates behavior by type ('company' vs 'drug'), giving concrete guidance for selecting the tool.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A4.4/5.0
Disambiguation5/5

Each tool has a distinct purpose; even similar tools like ask_pipeworx and ask_pipeworx_grounded are clearly differentiated by grounding behavior. Polymarket tools are separated by specific angles (arbitrage, edges, tracking, fill risk, cross-venue).

Naming Consistency5/5

All tool names use consistent snake_case with descriptive verbs (ask_, compare_, discover_, generate_, list_, recall_, etc.). No mixing of camelCase or other conventions.

Tool Count4/5

35 tools is on the higher end but justified by the breadth of functionality: Brazilian economics, Pipeworx data querying, company analysis, Polymarket betting, memory, subscriptions, etc. Each tool seems necessary, though a few could potentially be consolidated.

Completeness4/5

The tool set covers major CRUD operations and data retrieval across multiple domains. Minor gaps exist (e.g., no tool to edit subscriptions directly, but unsubscribe/resubscribe works). Overall, the surface is well-rounded for the stated purposes.